| MADISON, WI--(Marketwire - October 15, 2009) - | | | | research proposals to promote IMRT technology not |
| TomoTherapy Incorporated (NASDAQ: TOMO) | | | | previously available in France. |
| announced today that the Institute Curie Hospital in | | | | "The Institute Curie is among the most |
| France has purchased a second TomoTherapy® | | | | prestigious cancer research facilities in the world and |
| radiation therapy system, to support the increasing | | | | is well known for its high standard of care," |
| demand for intensity-modulated radiation therapy | | | | said Patrice Lompech, TomoTherapy sales manager in |
| (IMRT). The Institute Curie Hospital has been treating | | | | France. "The hospital's decision to expand its |
| cancer patients with TomoTherapy technology since | | | | TomoTherapy practice is further validation of the |
| March 2007, when it became the first hospital in | | | | platform's power for treating a wide variety of cases |
| France to adopt the technology. Now, with this most | | | | and demonstrates the confidence staff has in our |
| recent purchase, there are eight TomoTherapy | | | | platform, as they provide the highest quality 3D |
| systems in use in France to treat patients with | | | | image-guided treatments for patients." |
| routine, complex and rare cancers. | | | | The Institute Curie will present three TomoTherapy |
| "We typically treat our most complex cases -- | | | | treatment-related abstracts at the Annual Meeting of |
| such as sarcomas, head and neck tumors with | | | | the American Society for Radiation Oncology |
| multiple treatment volumes, and lung, pancreatic and | | | | (ASTRO) being held November 1-5, 2009, in Chicago. |
| liver cancers -- with TomoTherapy," said Dr. | | | | The scientific papers highlight Institute Curie's |
| Alain Fourquet, head of the Department of Radiation | | | | research work involving uncommon and clinically |
| Oncology at the Institute Curie Hospital. "The | | | | challenging cases in plasmocytoma and extensive |
| addition of a second unit will allow us to increase our | | | | malignant lymphoma in conjunction with stem cell |
| ability to care for more patients in need of advanced | | | | transplant, as well as preliminary studies on the use |
| radiation therapy and enable us to expand the types | | | | of TomoTherapy technology in breast cancer |
| of indications we can treat to include pelvic tumors | | | | treatment. |
| and some complicated cases of breast cancer. In | | | | About TomoTherapy Incorporated |
| addition, we hope to use the second TomoTherapy | | | | TomoTherapy Incorporated has developed, markets |
| system to assist us in conducting prospective clinical | | | | and sells the TomoTherapy® Hi·Art® |
| trials and research in physics projects." | | | | treatment system, an advanced radiation therapy |
| The Institute Curie is a private foundation combining | | | | system for the treatment of a wide variety of |
| France's largest cancer research center and a leading | | | | cancers. The Hi·Art treatment system |
| edge hospital. It was founded in 1909 by Marie Curie | | | | combines integrated CT imaging with conformal |
| with the primary purpose of defeating cancer, and it | | | | radiation therapy to deliver sophisticated radiation |
| received state approval as a foundation in 1921. | | | | treatments with speed and precision while reducing |
| Internationally renowned for its work in the diagnosis | | | | radiation exposure to surrounding healthy tissue. The |
| and treatment of cancers, the Institute Curie serves | | | | company's stock is traded on the NASDAQ Global |
| as a reference center throughout the world on the | | | | Select Market under the symbol TOMO. To learn |
| implementation of innovative treatments. | | | | more about TomoTherapy, please visit |
| The second TomoTherapy system at Institute Curie | | | | ©2009 TomoTherapy Incorporated. All rights |
| Hospital will replace an aging cobalt radiation machine. | | | | reserved. TomoTherapy, Tomo, the TomoTherapy |
| The small footprint of the TomoTherapy unit will | | | | logo and Hi·Art are among trademarks, |
| enable the hospital to install the new technology while | | | | service marks or registered trademarks of |
| minimizing the need for extensive remodeling. The | | | | TomoTherapy Incorporated in the United States and |
| hospital decided to purchase its first TomoTherapy | | | | other countries. |
| system after the National Cancer Institute called for | | | | |